標(biāo)題: Titlebook: Outcome Measures and Metrics in Systemic Lupus Erythematosus; Zahi Touma Book 2021 Springer Nature Switzerland AG 2021 Anxiety, depression [打印本頁] 作者: Ingrown-Toenail 時間: 2025-3-21 18:59
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus影響因子(影響力)
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus影響因子(影響力)學(xué)科排名
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus網(wǎng)絡(luò)公開度
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus被引頻次
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus被引頻次學(xué)科排名
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus年度引用
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus年度引用學(xué)科排名
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus讀者反饋
書目名稱Outcome Measures and Metrics in Systemic Lupus Erythematosus讀者反饋學(xué)科排名
作者: 皮薩 時間: 2025-3-21 23:02 作者: phlegm 時間: 2025-3-22 00:45
Assessment of Health-Related Quality of Life in Systemic Lupus Erythematosus,ore more useful when assessing patient-reported outcomes in clinical trials of new interventions for SLE patients. This chapter describes the content of generic and SLE-specific measures and presents evidence for the quality of the scale development and psychometric evaluation of the SLE-specific HR作者: 鋼筆記下懲罰 時間: 2025-3-22 06:18 作者: 致詞 時間: 2025-3-22 12:16 作者: reperfusion 時間: 2025-3-22 14:15 作者: 寒冷 時間: 2025-3-22 18:13 作者: palpitate 時間: 2025-3-22 22:14 作者: Implicit 時間: 2025-3-23 01:34
Taneisha K. McGhie,Dorcas E. Beaton,Diane Lacaille,Joan E. Wither,Jorge Sanchez-Guerrero,Zahi Touma (1:7). IgA from 33% of the breast cyst fluids examined and IgG from 10% of the fluids reacted with MuMTV. Antigen reactive with antiserum of MuMTV core protein p28 was located in a 165,000 g pellet of breast cyst fluids (6). Particles resembling the cores of retroviruses were observed in fractions 作者: 彈藥 時間: 2025-3-23 06:19
Diane L. Kamen,Eric Zollarslack of antibody to CMV in the IgM class, a delay in CMV-IgG antibody formation, and an unusually prolonged high titer of CMV excretion in his urine. In spite of these immunologic changes, he has not experienced opportunistic infections. This case study helps to clarify some of the above relationshi作者: 充足 時間: 2025-3-23 10:40 作者: 確定方向 時間: 2025-3-23 16:45 作者: CHURL 時間: 2025-3-23 18:30 作者: 要求比…更好 時間: 2025-3-23 23:28
Konstantinos Tselios,Dafna D. Gladman,Murray B. Urowitz analysis of the splicing of the tripartite leader sequence indicates that several rapid cleavages in the intron regions take place before exon-exon ligation occurs. The unligated pieces of RNA are bound to the nuclear matrix and it is therefore possible that the nuclear matrix provides the structur作者: 舊石器時代 時間: 2025-3-24 02:35
Taraneh Tofighi,Sindhu R. Johnson,Zahi Toumaged within the characteristic bullet-shaped lipid-containing shell that contains two other virus-specific proteins: a surface antigen glycoprotein designated G (molecular weight, 69,000) and a membrane-associated protein designated M (molecular weight, 26,000) located underneath the lipid bilayer.作者: discord 時間: 2025-3-24 09:38 作者: FLIC 時間: 2025-3-24 13:26 作者: PHONE 時間: 2025-3-24 17:58 作者: GROVE 時間: 2025-3-24 21:01
Lily McMorrow,Jerik Leung,Vibeke Strand,Alfred H. J. Kimn epidemiological information or inference. Several specific serological tests are now available for diagnostic and epidemiological studies of both type A and type B infections. Diagnosis of non-A, non-B hepatitis is still based on exclusion rather than specific serological tests, but the rapid and 作者: ascetic 時間: 2025-3-25 02:01
Lee-Suan Teh,Madhura Castelino,Kathleen McElhone,Janice Abbottections result in clinical illness. About 5% of common colds are caused by strain DC 43 in winter. Chapter 8, Cytomegalovirus: Sections on pathogenesis of CMV in relation to organ transplantation and mononucleosis, as well as sections on the risk and features of con- genital infection and disease, h作者: 束以馬具 時間: 2025-3-25 03:57 作者: demote 時間: 2025-3-25 07:52 作者: vitrectomy 時間: 2025-3-25 14:58
Prabjit Ajrawat,Vibeke Strand,Mark Matsos,Lee S. Simon,Zahi Toumasasters strike. Perhaps, in the long run, a vigorous and scientifically informed program of risk mitigation will reduce substantially, as hoped, the need for relief and rehabilitation programs. In the foreseeable future, however, it is likely that policies involving direct relief for and rehabilitat作者: notification 時間: 2025-3-25 17:36 作者: AND 時間: 2025-3-25 20:58 作者: 凝結(jié)劑 時間: 2025-3-26 00:12
Outcome Measures and Metrics in Systemic Lupus Erythematosus978-3-030-73303-2作者: 拋物線 時間: 2025-3-26 06:15 作者: 蔓藤圖飾 時間: 2025-3-26 08:46
978-3-030-73302-5Springer Nature Switzerland AG 2021作者: Magnitude 時間: 2025-3-26 13:24 作者: AXIOM 時間: 2025-3-26 18:32
https://doi.org/10.1007/978-3-030-73303-2Anxiety, depression, and fatigue in lupus patients; Assessment of disease activity and damage in lupu作者: 高調(diào) 時間: 2025-3-26 22:08
Clinical Aspects of Systemic Lupus Erythematosus,an awareness and appreciation of the protean manifestations of SLE is an imperative for the lupus doctor as well as those involved in lupus research. We attempt a broad discussion of these manifestations in this chapter.作者: radiograph 時間: 2025-3-27 01:16
Metrics of Damage in SLE, consideration include incorporation of novel descriptors, further psychometric testing of current SDI descriptors, a weighted scoring approach to items, and identifying items attributable to glucocorticoid use.作者: Project 時間: 2025-3-27 08:13 作者: 侵略主義 時間: 2025-3-27 09:47 作者: 輕浮思想 時間: 2025-3-27 16:56 作者: plasma-cells 時間: 2025-3-27 21:25
Diagnosis and Classification of Systemic Lupus Erythematosus,discuss the development of the 2019 EULAR/ACR classification criteria for SLE. We highlight many insights gained about the current thinking around the construct of SLE and implications for SLE diagnosis.作者: 非實體 時間: 2025-3-28 00:50
Metrics and Outcome Measures of Disease Activity and Damage in Childhood-Onset Systemic Lupus Erythal disease activity and damage metrics, as well as health-related quality of life indices have been developed as means of monitoring disease in an effort of adjusting therapy accordingly. This chapter focuses on disease metrics and outcome measures validated for use in cSLE.作者: amnesia 時間: 2025-3-28 05:00 作者: garrulous 時間: 2025-3-28 07:35
Book 2021f SLE is comprehensive and includes different core set domains; disease activity, damage, health-related quality of life,?adverse events and economic impact.?. This comprehensive book is focused on the instruments and outcome measures utilized in the assessment of SLE. It targets different audiences作者: Rinne-Test 時間: 2025-3-28 13:39
Introduction: Metrics and Domains Measured in SLE,in particular cognition, depression, and anxiety as well as fatigue. Having explored what needs to be measured in SLE, this chapter then outlines the decision-making process by which candidate instruments are identified and determined to be a match for the target construct (e.g., disease activity).作者: 表被動 時間: 2025-3-28 18:24
Challenges and Advances in SLE Autoantibody Detection and Interpretation,..As an approach to limiting morbidity and rising healthcare costs associated with SLE, the future of ANA testing should focus on making an accurate and actionable diagnosis of very early SLE. To achieve this goal, harmonization of autoantibody testing and machine learning analytics will be important.作者: anesthesia 時間: 2025-3-28 21:20 作者: ASTER 時間: 2025-3-29 01:23 作者: Collected 時間: 2025-3-29 05:24
Assessment of Depression and Anxiety in Lupus,es across studies of general population and rheumatic diseases, there are a lack of studies examining their use in SLE patients. Further research will be needed to develop consensus around disease-related cutoffs and to clarify the associations of disease- and patient-related factors in SLE.作者: 圖表證明 時間: 2025-3-29 08:56
Metrics and Outcomes of Systemic Lupus Erythematosus in Clinical Practice,es that recommend patient assessments using validated instruments of disease activity and validated disease damage metrics. We also provide an overview of several validated disease activity and damage metrics including the SLEDAI, SLAM, SLE-DAS, and BILAG.作者: coalition 時間: 2025-3-29 13:47
c approach to the metrics utilized in the assessment of dise.Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that manifests with a myriad of clinical and laboratory features. The assessment of SLE is comprehensive and includes different core set domains; disease activity, damage, 作者: FAZE 時間: 2025-3-29 17:36
Introduction: Metrics and Domains Measured in SLE,h and clinical settings: disease activity, chronic damage resulting from lupus activity or its treatment, health-related quality of life (HRQoL), adverse events, and economic impact. Emerging concepts in SLE such as frailty are also introduced along with deep insights on selected existing concepts, 作者: 粗魯性質(zhì) 時間: 2025-3-29 19:47 作者: 無孔 時間: 2025-3-30 01:44 作者: Tractable 時間: 2025-3-30 07:27 作者: 輕快來事 時間: 2025-3-30 12:05
Childhood-Onset Systemic Lupus Erythematosus (cSLE): Is It Really Different Than Adult-Onset SLE?,aSLE)? We review the existing literature on similarities and differences of important disease aspects in both cSLE and aSLE including epidemiology, genetics, classification criteria, medication use, mental health, growth and development, and social outcomes. As race may influence observed difference作者: Platelet 時間: 2025-3-30 12:33
Metrics in Disease Activity Measures in Systemic Lupus Erythematosus,age, as well as drug-related adverse events, all of which impact their quality of life and overall prognosis. Close monitoring of all these aspects and appropriate attribution to the occasional pathogenic process (disease activity or irreversible damage) is essential for the optimal management of th作者: 對手 時間: 2025-3-30 19:21
Metrics of Damage in SLE,agement of disease. As SLE is a multisystem, complex illness that varies with time, accurate assessment of damage relies on the use of standardized instruments with demonstrable psychometric properties. In this chapter, we explore the development of the SLICC/ACR damage index (SDI) and appraise the 作者: 不近人情 時間: 2025-3-30 23:38 作者: Ornament 時間: 2025-3-31 00:53
Pregnancies in Lupus: Monitoring and Metrics,?years. SLE pregnancies are associated with higher maternal and fetal morbidity and mortality. As such, these pregnancies are high-risk, requiring close and careful monitoring by the rheumatologist and maternal-fetal medicine specialist, and sometimes others, throughout pregnancy and postpartum. Adv作者: Gyrate 時間: 2025-3-31 05:23 作者: Musculoskeletal 時間: 2025-3-31 10:23 作者: temperate 時間: 2025-3-31 16:34 作者: 憤怒歷史 時間: 2025-3-31 19:17 作者: 舊式步槍 時間: 2025-3-31 23:56 作者: AROMA 時間: 2025-4-1 05:02 作者: 獨(dú)特性 時間: 2025-4-1 07:54 作者: semble 時間: 2025-4-1 10:49
Work Disability and Prevention in SLE: A Focus on Assessment and Function, disability and mortality. For SLE patients, work disability is related to personal challenges, including limitations in functioning, decreased income, activity participation restrictions, and diminished health-related quality of life. In order to address these challenges, work disability in patient
